Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!

BigHat Biosciences is a Series B biotech company based outside San Francisco, focused on developing safer and more effective antibody therapies using machine learning and synthetic biology. Their…

BigHat Biosciences is a Series B biotech company based outside San Francisco, focused on developing safer and more effective antibody therapies using machine learning and synthetic biology. Their…
Founded: 2019
Headquarters region: San Mateo / San Carlos, CA area
Core focus: AI-driven antibody discovery and engineering
Tech/Platform: Milliner platform combining ML, synthetic biology, and high-speed wet lab
Latest disclosed round: Series B $75M (Jul 20, 2022)
Notable investors: Section 32, Andreessen Horowitz, Amgen Ventures, Bristol-Myers Squibb, 8VC
Antibody therapeutics discovery and engineering
2019
Biotechnology Research
$5M (approximate)
Seed financing reported as approximately $5 million
$19M
Oversubscribed Series A
$75M
Series B participation included Amgen Ventures, Bristol Myers Squibb, Quadrille Capital, Gaingels, and others
“Company has participation from strategic biopharma investors and large venture firms (e.g., Section 32, Amgen Ventures, Bristol-Myers Squibb, Andreessen Horowitz)”
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
| Company |
|---|